Is intensive treatment beneficial to elderly patients with ANLL?
Harousseau
J L
JL
Department of Hematology, Hôtel Dieu, Nantes, France.
D000208:Acute Disease; D000368:Aged; D003561:Cytarabine / Q000627:therapeutic use*; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D011379:Prognosis; D012008:Recurrence; D012074:Remission Induction
D003561:Cytarabine